Product Description
Experience the acclaimed Degarelix for Injection 80 mg, a sterling pharmaceutical achievement designed for adult men with advanced hormone-dependent prostate cancer. Delivered in a single-dose vial (80 mg) with solvent for reconstitution, this magnificent therapy offers rapid action through subcutaneous injection. Its clear, colorless to slightly yellow solution assures purity, while the ready-to-reconstitute powder ensures convenience. Take advantage of this last chance option with a remarkable shelf life of 24 months. Store below 25C, away from light, and consult packaging for market authorization details. Prescription only.
Degarelix 80 mg: Uses, Distinct Advantages, and Features
Degarelix for Injection 80 mg is prominently used in the treatment of advanced hormone-dependent prostate cancer in adult males. The advantage of this synthetic peptide antagonist lies in its ready-to-reconstitute, sterile packaging and its rapid action when injected subcutaneously. Extra features include its odorless nature, white to off-white lyophilized powder appearance, and convenient storage requirements. Clinicians and patients can trust the products reliability and proven efficacy in controlling disease progression when timely administered.
Distribution, Payment Terms, and Shipping Information
Degarelix for Injection 80 mg is extensively available across the main domestic markets of India. Shipped goods are carefully handled from recognized FOB Ports, ensuring safe delivery and order completion. Flexible payment terms provide ease and transparency for clients, including options for exchange depending on distributor or trading agreements. Recognized suppliers, exporters, and wholesalers guarantee reliable sourcing, maintaining product integrity and customer satisfaction throughout the transaction process.
FAQs of Degarelix for Injection 80 mg:
Q: How should Degarelix for Injection 80 mg be reconstituted before use?
A: Reconstitute Degarelix for Injection 80 mg by adding the supplied 4.2 mL solvent immediately before administration. Gently swirl until a clear, colorless to slightly yellow solution is formed. Use the reconstituted solution within the recommended time as indicated in the product insert.
Q: What are the main therapeutic benefits of Degarelix for Injection 80 mg?
A: Degarelix for Injection 80 mg effectively treats advanced hormone-dependent prostate cancer by acting as a synthetic peptide antagonist, providing fast and sustained suppression of testosterone, which helps manage and slow tumor progression.
Q: When should this medication be administered to patients?
A: Degarelix for Injection 80 mg should be administered only after a confirmed diagnosis of advanced hormone-dependent prostate cancer in adult male patients, as prescribed by a qualified healthcare professional.
Q: Where can I obtain detailed market authorization and distributor information?
A: Detailed market authorization holder, distributor, or manufacturer information can be found on the package label, tailored according to regional regulations and supply chains.
Q: What are the storage guidelines for Degarelix for Injection 80 mg vials?
A: Store Degarelix for Injection 80 mg below 25C (77F), protect the vials from light, and do not freeze. Proper storage ensures the products efficacy throughout its 24-month shelf life.
Q: How is the product shipped and what are the payment options?
A: The product is shipped securely via recognized FOB ports and can be ordered from trusted Indian suppliers and exporters. Payment terms are flexible and may include options for exchange as per trading partner agreements.